Scholarly Index
Peter H. Fishman
Novartis (United States); 10,029 total citations; 188 total publications; best world rank #143
Novartis (United States)
10,029Total citations
188Total publications
55H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Glycosylation and Glycoproteins Research | Lifetime | 472 | US 221 | 98.48 |
| Toxin Mechanisms and Immunotoxins | Lifetime | 198 | US 106 | 97.88 |
| Carbohydrate Chemistry and Synthesis | Lifetime | 482 | US 171 | 97.90 |
| Cancer, Stress, Anesthesia, and Immune Response | Lifetime | 143 | US 79 | 96.54 |
| Galectins and Cancer Biology | Lifetime | 477 | US 160 | 95.60 |
| Escherichia coli research studies | Lifetime | 879 | US 329 | 94.09 |
| Proteoglycans and glycosaminoglycans research | Lifetime | 949 | US 369 | 93.08 |
| Caveolin-1 and cellular processes | Lifetime | 816 | US 336 | 84.09 |